PAF Co-Pay Relief: Psoriasis

Funded
About
The PAF Co-Pay Relief: Psoriasis program offers substantial benefits for patients needing assistance with the cost of medications for psoriasis. The program supports a wide range of FDA-approved drugs, including Cimzia, Cosentyx, and Enbrel, and ensures patients receive funding quickly upon approval. With its comprehensive coverage and income verification process, the PAF Co-Pay Relief: Psoriasis program is an essential resource for reducing the financial burden on eligible patients insured under Medicare, Medicaid, or Military Benefits residing in the United States.
Insurance requirements: Medicare / Medicaid
Enrollment Forms
PAF Co-Pay Relief: Psoriasis
Benefits
$2500 annual maximum benefit
Program Requirements
Valid only for residents in the US and Puerto Rico
Enrollment Required: Yes
Coverage Required: No
Needs Based: Yes
Activation Required: No
Program Details
Specific drug coverage is not indicated on program website; drug coverage must be verified by calling program at 18665123861
Patients may complete the application online or by phone; once approved, patients will begin receiving funding immediately
All patients approved for assistance are required to have their diagnosis and treatment verified by a member of the patient’s care team within 30 days of approval
The CoPay Relief Program will confirm the patient's reported income to ensure that it is within the income eligibility guidelines for the program through an income verification screening process
If patient's reported income is unable to be verified, a letter will be sent requesting proof of income documents be submitted to our program within 30 days for continued eligibility. Approved patients who do not comply with the request for income documentation within 30 days will forfeit their award
Approved patients who have a household income in excess of program guidelines upon review of submitted income documentation will no longer qualify for continued support, will forfeit their award and will not be eligible to reapply for the program until 12 months from the original date of approval
Approved patients understand and agree that if they do not comply with the request for income documentation will no longer qualify for continued support, will forfeit their award and will not be eligible to reapply for the program until 12 months from the original date of approval
Patients can continue to submit claims for payment during this income verification period
Claims can be submitted to CPR for payment via Virtual Pharmacy Card, electronic upload into the portal, faxed using the unique barcoded fax cover sheet or mailed
Claims can be paid via Virtual Pharmacy Card, Electronic Funds Transfer (EFT) or check
Approved patients who exceed 120 days with no processed claims at any time during their 12 month award period will forfeit their award. Patients who forfeit their award due to lack of utilization are not eligible to reapply for the program until 12 months from the original date of approval. Uninsured patients are ineligible UNLESS they have had coverage within the previous 6 months
Foundation covers all drugs that are FDAindicated for the diagnosis. If physician prescribes an offlabel medication, and the insurance company will pay for it, the foundation will also cover it
Other Tools for Taltz